Trials / Conditions / Post-Polycythemia Vera
Post-Polycythemia Vera
3 registered clinical trials studyying Post-Polycythemia Vera.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Completed | An Efficacy and Safety Study of Fedratinib Compared to Best Available Therapy in Subjects With DIPSS-intermedi NCT03952039 | Celgene | Phase 3 |
| Completed | Safety Study Evaluating Twice-Daily Administration of Momelotinib in Primary Myelofibrosis or Post-Polycythemi NCT01423058 | Sierra Oncology LLC - a GSK company | Phase 1 / Phase 2 |
| Terminated | A Study to Evaluate Safety and Efficacy of Panobinostat in Participants With Primary Myelofibrosis NCT00931762 | Novartis Pharmaceuticals | Phase 2 |